Published in JAMA Intern Med on March 01, 2014
Action to Control Cardiovascular Risk in Diabetes (ACCORD) (ACCORD) | NCT00000620
CAP-advancing the evaluation of preclinical Alzheimer disease treatments. Nat Rev Neurol (2015) 1.05
Population attributable risks of hypertension and diabetes for cardiovascular disease and stroke in the northern Manhattan study. J Am Heart Assoc (2014) 0.88
Impact of Hypertension on Cognitive Function: A Scientific Statement From the American Heart Association. Hypertension (2016) 0.87
Cardiovascular risk factors and cognitive decline in older people with type 2 diabetes. Diabetologia (2015) 0.82
Diabetes. Cognitive decline and T2DM--a disconnect in the evidence? Nat Rev Endocrinol (2014) 0.79
The impact of diabetes on cognitive decline: potential vascular, metabolic, and psychosocial risk factors. Alzheimers Res Ther (2015) 0.79
Poorly controlled cholesterol is associated with cognitive impairment in T2DM: a resting-state fMRI study. Lipids Health Dis (2015) 0.76
p38 MAPK Inhibition Improves Synaptic Plasticity and Memory in Angiotensin II-dependent Hypertensive Mice. Sci Rep (2016) 0.76
Cardiovascular guidelines: separate career may help attenuate controversy. Cardiovasc Diabetol (2014) 0.76
The continuing challenge of turning promising observational evidence about risk for dementia to evidence supporting prevention. JAMA Intern Med (2014) 0.75
Predictors of Cognitive Decline in Older Adult Type 2 Diabetes from the Veterans Affairs Diabetes Trial. Front Endocrinol (Lausanne) (2016) 0.75
Intensive blood pressure lowering does not reduce cognitive decline in people with diabetes, study finds. BMJ (2014) 0.75
Caloric restriction improves diabetes-induced cognitive deficits by attenuating neurogranin-associated calcium signaling in high-fat diet-fed mice. J Cereb Blood Flow Metab (2015) 0.75
Management of Adults With Diabetes and Cognitive Problems. Diabetes Spectr (2016) 0.75
Comparative Proteomic Analysis of the Mitochondria-associated ER Membrane (MAM) in a Long-term Type 2 Diabetic Rodent Model. Sci Rep (2017) 0.75
Primary and Secondary Prevention Trials in Alzheimer Disease: Looking Back, Moving Forward. Curr Alzheimer Res (2016) 0.75
Association between Low-density lipoprotein cholesterol and occipital periventricular hyperintensities in a group of Chinese patients: an observational study. Lipids Health Dis (2017) 0.75
Associations between anxiety and depression symptoms and cognitive testing and neuroimaging in type 2 diabetes. J Diabetes Complications (2015) 0.75
"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res (1975) 301.74
The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med (2001) 76.04
Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med (2008) 47.90
The Cardiovascular Health Study: design and rationale. Ann Epidemiol (1991) 27.24
Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med (2010) 21.49
Effects of combination lipid therapy in type 2 diabetes mellitus. N Engl J Med (2010) 16.40
Clinical and biomarker changes in dominantly inherited Alzheimer's disease. N Engl J Med (2012) 14.14
Statistics in medicine--reporting of subgroup analyses in clinical trials. N Engl J Med (2007) 12.55
Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods. Am J Cardiol (2007) 9.62
Long-term effects of intensive glucose lowering on cardiovascular outcomes. N Engl J Med (2011) 8.14
Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol (2006) 6.97
Cognitive decline and dementia in diabetes--systematic overview of prospective observational studies. Diabetologia (2005) 4.19
An image-processing system for qualitative and quantitative volumetric analysis of brain images. J Comput Assist Tomogr (1998) 3.49
Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy. Lancet Neurol (2011) 3.25
Differences in diabetes prevalence, incidence, and mortality among the elderly of four racial/ethnic groups: whites, blacks, hispanics, and asians. Diabetes Care (2004) 2.80
Hypertension and cerebral white matter lesions in a prospective cohort study. Brain (2002) 2.31
Computer-assisted segmentation of white matter lesions in 3D MR images using support vector machine. Acad Radiol (2008) 2.25
Magnetic resonance imaging of the brain in diabetes: the Cardiovascular Determinants of Dementia (CASCADE) Study. Diabetes (2004) 2.17
NIDDM and blood pressure as risk factors for poor cognitive performance. The Framingham Study. Diabetes Care (1997) 1.89
The Action to Control Cardiovascular Risk in Diabetes Memory in Diabetes Study (ACCORD-MIND): rationale, design, and methods. Am J Cardiol (2007) 1.85
Stroop interference: aging effects assessed with the Stroop Color-Word Test. Exp Aging Res (1993) 1.77
White matter abnormalities in mobility-impaired older persons. Neurology (2000) 1.61
Automated measurement of brain and white matter lesion volume in type 2 diabetes mellitus. Diabetologia (2007) 1.45
Antihypertensive treatment and change in blood pressure are associated with the progression of white matter lesion volumes: the Three-City (3C)-Dijon Magnetic Resonance Imaging Study. Circulation (2011) 1.32
Diabetes and brain aging: epidemiologic evidence. Curr Diab Rep (2005) 1.27
Type 2 diabetes mellitus and cognition: an understudied issue in women's health. J Psychosom Res (2003) 1.21
Association of type 2 diabetes with depression, brain atrophy, and reduced fine motor speed in a 60- to 64-year-old community sample. Am J Geriatr Psychiatry (2008) 1.01
Medial temporal lobe atrophy and white matter hyperintensities are associated with mild cognitive deficits in non-disabled elderly people: the LADIS study. J Neurol Neurosurg Psychiatry (2005) 0.96
Statin therapy in the treatment of Alzheimer disease: what is the rationale? Am J Med (2005) 0.87
Primary Results of the Patient-Centered Disease Management (PCDM) for Heart Failure Study: A Randomized Clinical Trial. JAMA Intern Med (2015) 0.89
Brain MRI Volume Findings in Diabetic Adults With Albuminuria: The ACCORD-MIND Study. J Gerontol A Biol Sci Med Sci (2015) 0.75
Faster brain shrinkage in the ACCORD MIND study-reply. JAMA Intern Med (2015) 0.75